Zomedica Pharmaceuticals
ZOM49
$0.09arrow_drop_down0.20%-$0.00
Penny Stock
ZOM49
$0.09
arrow_drop_down0.20%Performance History
| Key Stats | |
|---|---|
| Open | $0.09 |
| Prev. Close | $0.09 |
| EPS | -0.06 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $95.34M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.09 | 0.09 |
| 52 Week Range | 0.09 | 0.22 |
| Ratios | |
|---|---|
| EPS | -0.06 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Zomedica Pharmaceuticals (ZOM)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Mr. Larry C. Heaton II
- Headquarters
- Ann Arbor
- Employees
- 85
- Exchange
- NYSE
Keep an eye on Zomedica Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Zomedica Pharmaceuticals (ZOM) stock price performance year to date (YTD)?
As of the latest data, Zomedica Pharmaceuticals (ZOM) has a year-to-date price change of -19.42%. Over the last three months, the change has been -17.91%. Over the past six months, the figure is -25.33%. Looking at a longer horizon, the five-year price change stands at -54.98%.
help
What is Zomedica Pharmaceuticals's (ZOM) price per share?
The current price per share for Zomedica Pharmaceuticals (ZOM) is $0.1. The stock has seen a price change of -$0 recently, indicating a -0.21% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Zomedica Pharmaceuticals (ZOM)?
For Zomedica Pharmaceuticals (ZOM), the 52-week high is $0.23, which is 136.81% from the current price. The 52-week low is $0.1, the current price is 1.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Zomedica Pharmaceuticals (ZOM) a growth stock?
Zomedica Pharmaceuticals (ZOM) has shown an average price growth of -1.65% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zomedica Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
Is Zomedica Pharmaceuticals (ZOM) a profitable company?
Zomedica Pharmaceuticals (ZOM) has a net income of -$34.53M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.76% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -147.5% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $25.19M, with a revenue growth rate of 33.05%, providing insight into the company's sales performance and growth. The gross profit is $17.32M. Operating income is noted at -$31.59M. Furthermore, the EBITDA is -$30.45M.
help
What is the market capitalization of Zomedica Pharmaceuticals (ZOM)?
Zomedica Pharmaceuticals (ZOM) has a market capitalization of $95.35M. The average daily trading volume is 0.1, indicating the stock's liquidity and investor engagement.